Cholesterol-Lowering Claim Disease Status Protested By McNeil
This article was originally published in The Tan Sheet
Executive Summary
McNeil Consumer Healthcare opposes FDA's classification of certain cholesterol-lowering claims as disease claims in the final rule on dietary supplement structure/function claims. In a Feb. 7 citizen petition, McNeil asks the agency to reconsider its decision.